SCHEMBL6251771

SCHEMBL6251771

FC(CN(Cc1ccccc1)Cc1ccccc1)CN(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
TSHR P16473 4/20 0.44
KDM4E B2RXH2 2/20 0.43
CNR2 P34972 1/20 0.42
AOC3 Q16853 1/20 0.41
HTT P42858 1/20 0.40
OPRK1 P41145 3/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2A P28223 1/20 0.39
SLC6A4 P31645 1/20 0.39
ADRA1A P35348 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KCNH2 Q12809 1/20 0.39
POLB P06746 1/20 0.39
TRPA1 O75762 1/20 0.39
OPRM1 P35372 2/20 0.38
OPRD1 P41143 2/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25348200 0.90 TSHR (0.52) ALDH1A1TSHRKDM4ECNR2AOC3
SCHEMBL28586963 0.90 ALDH1A1 (0.40) ALDH1A1TSHRKDM4ECNR2AOC3
SCHEMBL12881360 0.90 SLC6A2 (0.44) ALDH1A1TSHRKDM4ECNR2AOC3
SCHEMBL3439186 0.88 PNP (0.43) ALDH1A1TSHRKDM4ECNR2HTT
SCHEMBL83748 0.88 PNP (0.43) ALDH1A1TSHRKDM4ECNR2HTT
SCHEMBL29057663 0.88 AOC3 (0.41) ALDH1A1TSHRKDM4ECNR2AOC3
SCHEMBL10315714 0.88 KDM4E (0.46) ALDH1A1TSHRKDM4ECNR2AOC3
SCHEMBL13657504 0.88 PNP (0.43) ALDH1A1TSHRKDM4ECNR2HTT
SCHEMBL15688747 0.83 POLB (0.42) ALDH1A1TSHRKDM4ECNR2AOC3
SCHEMBL21328902 0.83 POLB (0.42) ALDH1A1TSHRKDM4ECNR2AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2875021-B1 BETA AMINO ACID DERIVATIVES AS INTEGRIN ANTAGONISTS UNIV SAINT LOUIS (US) 2017-08-23 EP disclosed
US-9085606-B2 Beta amino acid derivatives as integrin antagonists SAINT LOUIS UNIVERSITY (US) 2015-07-21 US disclosed
US-9085606-B2 Beta amino acid derivatives as integrin antagonists SAINT LOUIS UNIVERSITY (US) 2015-07-21 US disclosed
US-20140038910-A1 Beta Amino Acid Derivatives as Integrin Antagonists SAINT LOUIS UNIVERSITY (US) 2014-02-06 US disclosed
EP-1572210-A1 THE R-ISOMER OF BETA AMINO ACID COMPOUNDS AS INTEGRIN RECEPTOR ANTAGONISTS DERIVATIVES Pharmacia Corporation (US) 2005-09-14 EP disclosed
US-20050020505-A1 R-isomer of beta amino acid compounds as integrin receptor antagonists derivatives PHARMACIA CORPORATION 2005-01-27 US disclosed
WO-2004060376-A1 THE R-ISOMER OF BETA AMINO ACID COMPOUNDS AS INTEGRIN RECEPTOR ANTAGONISTS DERIVATIVES PHARMACIA CORPRATION (US) 2004-07-22 WO disclosed
WO-2004060376-A1 THE R-ISOMER OF BETA AMINO ACID COMPOUNDS AS INTEGRIN RECEPTOR ANTAGONISTS DERIVATIVES PHARMACIA CORPRATION (US) 2004-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140038910-A1 Beta Amino Acid Derivatives as Integrin Antagonists ITGB2, ITGAL, ITGB1 ALDH1A1 919/4885TSHR 1355/4885KDM4E 3525/4885
US-20050020505-A1 R-isomer of beta amino acid compounds as integrin receptor antagonists derivatives ITGA5, ITGAL, ITGB5 ALDH1A1 2118/4885TSHR 684/4885KDM4E 2745/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.